APA (7th ed.) Citation

N, H. N., H, R., YS, E., FH, S., JH, K., & SJ, K. (2025). Exploring chalcone-sulfonyl piperazine hybrids as anti-diabetes candidates: Design, synthesis, biological evaluation, and molecular docking study. Molecular diversity, 29(1), 43. https://doi.org/10.1007/s11030-024-10831-x

Chicago Style (17th ed.) Citation

N, Hosseini Nasab, Raza H, Eom YS, Shah FH, Kwak JH, and Kim SJ. "Exploring Chalcone-sulfonyl Piperazine Hybrids as Anti-diabetes Candidates: Design, Synthesis, Biological Evaluation, and Molecular Docking Study." Molecular Diversity 29, no. 1 (2025): 43. https://doi.org/10.1007/s11030-024-10831-x.

MLA (9th ed.) Citation

N, Hosseini Nasab, et al. "Exploring Chalcone-sulfonyl Piperazine Hybrids as Anti-diabetes Candidates: Design, Synthesis, Biological Evaluation, and Molecular Docking Study." Molecular Diversity, vol. 29, no. 1, 2025, p. 43, https://doi.org/10.1007/s11030-024-10831-x.